SCHEMBL8330114

SCHEMBL8330114

O=c1c2ccccc2ccc2cccnc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.58
CYP3A4 P08684 3/20 0.58
KDM4E B2RXH2 2/20 0.58
MAPT P10636 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
CCR1 P32246 2/20 0.58
CCR5 P51681 2/20 0.58
CCR8 P51685 2/20 0.58
MMP2 P08253 2/20 0.58
TSHR P16473 2/20 0.58
GMNN O75496 1/20 0.58
TP53 P04637 1/20 0.58
HSP90AA1 P07900 1/20 0.58
CYP2D6 P10635 1/20 0.58
MMP9 P14780 1/20 0.58
ALOX15 P16050 1/20 0.58
NFKB1 P19838 1/20 0.58
MMP8 P22894 1/20 0.58
THPO P40225 1/20 0.58
MTOR P42345 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13859958 0.85 LMNA (0.72) LMNACYP3A4KDM4EMAPTSMN1; SMN2
1-Naphthoquinoline SCHEMBL29533982 0.83 LMNA (0.69) LMNACYP3A4KDM4EMAPTSMN1; SMN2
Phenanthrene SCHEMBL16685315 0.83 CCR1 (0.76) LMNACYP3A4KDM4EMAPTSMN1; SMN2
1-Naphthoquinoline SCHEMBL15106 0.83 LMNA (0.69) LMNACYP3A4KDM4EMAPTSMN1; SMN2
1-Naphthoquinoline SCHEMBL262791 0.81 LMNA (0.67) LMNACYP3A4KDM4EMAPTSMN1; SMN2
1-Naphthoquinoline SCHEMBL3045500 0.81 LMNA (0.67) LMNACYP3A4KDM4EMAPTSMN1; SMN2
1-Naphthoquinoline SCHEMBL31141994 0.81 LMNA (0.67) LMNACYP3A4KDM4EMAPTSMN1; SMN2
SCHEMBL3193877 0.81 LMNA (0.67) LMNACYP3A4KDM4EMAPTSMN1; SMN2
1-Naphthoquinoline SCHEMBL31286254 0.81 LMNA (0.67) LMNACYP3A4KDM4EMAPTSMN1; SMN2
1-Naphthoquinoline SCHEMBL6340901 0.81 LMNA (0.67) LMNACYP3A4KDM4EMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0915869-A1 NOVEL TRICYCLIC N-CYANOIMINES USEFUL AS INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE SCHERING CORPORATION (US) 1999-05-19 EP disclosed
WO-1998040376-A1 PROCESS FOR PREPARING 1,4-DISUBSTITUTED PIPERIDINE COMPOUNDS CILAG AG (CH) 1998-09-17 WO disclosed
WO-1998004545-A1 NOVEL TRICYCLIC N-CYANOIMINES USEFUL AS INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE SCHERING CORPORATION (US) 1998-02-05 WO disclosed
WO-1996031505-A1 TRICYCLIC COMPOUNDS USEFUL FOR INHIBITION OF G-PROTEIN FUNCTION AND FOR TREATMENT OF PROLIFERATIVE DISEASES PHARMACOPEIA, INC. (US) 1996-10-10 WO disclosed
EP-0723540-A1 TRICYCLIC AMIDE AND UREA COMPOUNDS USEFUL FOR INHIBITION OF G-PROTEIN FUNCTION AND FOR TREATMENT OF PROLIFERATIVE DISEASES SCHERING CORPORATION (US) 1996-07-31 EP disclosed
EP-0535152-A1 BIS-BENZO OR BENZOPYRIDO CYCLO HEPTA PIPERIDENE, PIPERIDYLIDENE AND PIPERAZINE COMPOUNDS AND COMPOSITIONS. SCHERING CORP (US) 1993-04-07 EP disclosed
EP-0471750-A1 HETEROCYCLIC N-OXIDE DERIVATIVES OF SUBSTITUTED BENZO 5,6]CYCLOHEPTAPYRIDINES, COMPOSITIONS AND METHODS OF USE SCHERING CORPORATION (US) 1992-02-26 EP disclosed
WO-1990013548-A1 HETEROCYCLIC N-OXIDE DERIVATIVES OF SUBSTITUTED BENZO[5,6]CYCLOHEPTAPYRIDINES, COMPOSITIONS AND METHODS OF USE SCHERING CORPORATION (US) 1990-11-15 WO disclosed
EP-0288640-A1 6,11-Dihydro-11-(4-piperidylidene)-5H-benzo[5,6]cyclohepta-[1,2-b]pyridines and compositions and methods of use SCHERING CORPORATION (US) 1988-11-02 EP disclosed
US-4639457-A CARDIOTONIC AGENTS MERCK & CO., INC. (US) 1987-01-27 US disclosed
EP-0002512-B1 IMINO-BRIDGED BENZOCYCLOHEPTAPYRIDINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION THEREOF MERCK & CO. INC. (US) 1984-02-22 EP disclosed
US-4229455-A MUSCLE RELAXANTS, TRANQUILIZERS MERCK & CO., INC. (US) 1980-10-21 US disclosed
EP-0002512-A1 Imino-bridged benzocycloheptapyridines, process for their preparation and pharmaceutical composition thereof MERCK & CO. INC. (US) 1979-06-27 EP disclosed